Companies
Murugappa Group to inject Rs.1300 crore on business expansion during current fiscal
By Sakshi Ganguli
Font Scale: 
Posted 06 May 2008 @ 03:54 pm GMT
A webshot of Murugappa Group's corporate homepage. Chennai-based business conglomerate, Murugappa Group said it has set aside Rs.1300 crore ($325 million) in the current fiscal towards business expansion.
Article Tags 
distillery fertiliser group murugappa parry refinery sanitaryware sugar
About the Murugappa Group
The Murugappa Group, headquartered in Chennai, India, is a $2 billion (Rs.8000 crore) conglomerate with interests in engineering, abrasives, sanitaryware, fertilisers, finance, bio-products and plantations. It has 29 companies under its umbrella, of which eight are listed and actively traded on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). Altogether, the companies employ over 28,000 people. With 40 units spread across 12 states in India, the Murugappa Group is one of India's oldest business houses. It also has a presence in The UK, The USA, Australia, Canada, South Africa, UAE, Thailand, and China.
Next Page
This article is copyrighted by Ibtimes.com.
Most Popular Stories
- 1 Indias inflation rate rises marginally to 11.91 percent, prices seen stabilizing
- 2 Volkswagen launches Jetta in India, aims to raise sales with new models
- 3 No annexures, TDS or TCS certificates required for filing I-T returns: CBDT
- 4 BSE Sensex jumps 536 points to close above 13K as global crude oil prices, inflation seen moderating
- 5 Dark Knight sets box office record with $66.4M
- 6 Maytas Properties launches "walk to work" IT-ITeS SEZ in Hyderabad
- 7 Satyams FY09 Q1 net profit rises 45 percent on new orders, weaker rupee
- 1 Wipro's FY09 Q1 net profit rises 25 percent, cautious on outlook
- 2 UltraTech's net profit up 2 percent in FY09 Q1, warns of "surplus scenario" in future
- 3 Satyam's FY09 Q1 net profit rises 45 percent on new orders, weaker rupee
- 4 Biocon teams up with Abraxis BioScience, launches breast cancer drug Abraxane in India
- 5 Biocon's net profit drops 72 percent in Q1 of FY09 due to rupee volatility, absence of licensing income
- 6 No annexures, TDS or TCS certificates required for filing I-T returns: CBDT
- 7 Maytas Properties launches "walk to work" IT-ITeS SEZ in Hyderabad
Top Stories on Companies
- 1 Wipro's FY09 Q1 net profit rises 25 percent, cautious on outlook
- 2 UltraTech's net profit up 2 percent in FY09 Q1, warns of "surplus scenario" in future
- 3 Satyam's FY09 Q1 net profit rises 45 percent on new orders, weaker rupee
- 4 Biocon teams up with Abraxis BioScience, launches breast cancer drug Abraxane in India
- 5 Biocon's net profit drops 72 percent in Q1 of FY09 due to rupee volatility, absence of licensing income
- 6 Citigroup posts $2.5B loss, but beats expectations
- 7 Maytas Properties launches "walk to work" IT-ITeS SEZ in Hyderabad
|
|
